BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 3361753)

  • 1. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis.
    Grond J; Koudstaal J; Elema JD
    Kidney Int; 1985 Feb; 27(2):405-10. PubMed ID: 3990093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis.
    Grond J; Beukers JY; Schilthuis MS; Weening JJ; Elema JD
    Lab Invest; 1986 Jan; 54(1):77-83. PubMed ID: 3941543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.
    Seckin I; Uzunalan M; Pekpak M; Kokturk S; Sonmez H; Oztürk Z; Demirci S; Yaprak E
    J Biomed Sci; 2012 Feb; 19(1):24. PubMed ID: 22335899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J; Elema JD
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    Ren Physiol; 1986; 9(6):366-74. PubMed ID: 3602582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular sclerotic lesions in the rat. Histochemical analysis of their macromolecular and cellular composition.
    Grond J; van Goor H; Erkelens DW; Elema JD
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):521-34. PubMed ID: 2878525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
    Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A
    Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on correlation between aminonucleoside induced experimental focal glomerular sclerosis and mesangial dysfunction in rats (author's transl)].
    Sawaguchi H
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):109-24. PubMed ID: 7098139
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.
    Elema JD; Weening JJ; Grond J
    Contrib Nephrol; 1988; 60():73-82. PubMed ID: 3278860
    [No Abstract]   [Full Text] [Related]  

  • 15. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis.
    Ryan GB; Karnovsky MJ
    Kidney Int; 1975 Oct; 8(4):219-32. PubMed ID: 1104966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal structural abnormalities following recovery from acute puromycin nephrosis.
    Rasch R; Nyengaard JR; Marcussen N; Meyer TW
    Kidney Int; 2002 Aug; 62(2):496-506. PubMed ID: 12110010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular sclerosis in Wistar rats: analysis of its variable occurrence after unilateral nephrectomy.
    Grond J; van Goor H; Erkelens DW; Elema JD
    Br J Exp Pathol; 1986 Aug; 67(4):473-9. PubMed ID: 3741773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
    Shiiki H; Sasaki Y; Nishino T; Kimura T; Kurioka H; Fujimoto S; Dohi K
    Pathobiology; 1998; 66(5):221-9. PubMed ID: 9732237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.